Pharm Tech Minutes 2022.02.04: Difference between revisions
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
Michael tan (talk | contribs) |
||
| Line 23: | Line 23: | ||
===Strategy and stakeholder discussion=== | |||
* Could the patient be a stakeholder? The aim is to improve the quality of information. | |||
** In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles. | ** In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles. | ||
** In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID. | ** In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID. | ||
** In Switzerland Anne has to go the post office. | ** In Switzerland Anne has to go the post office. | ||
** Joao mentions that a product catalogue is important. Without this you cannot make a | ** Joao mentions that a product catalogue is important. Without this you cannot make a concise medication list.. | ||
** | ** You also need an organization to maintain the medication structure for the catalogue. | ||
** | ** This topic is likely to be discussed in Unicom as well. We should approach Unicom to investigate if there is a need for a profile. | ||
** Michael will approach Christian Hay to see if | ** Michael will approach Christian Hay to see if IHE Pharmacy could provide any added value | ||
* Our team needs to set up a marketing plan. | |||
** We need to identify the opportunities and work out the business case. | |||
** Nowadays a standard can only be certified if it manages to reach a certain maturity level. | |||
** That means that users have to implement the standard. | |||
===Supply (Project lead: Jose)=== | |||
** White paper has been reviewed and updated. The documents can be found here: | ** White paper has been reviewed and updated. The documents can be found here: | ||
https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr | https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr | ||
| Line 42: | Line 45: | ||
http://build.fhir.org/ig/IHE/pharm-supply/index.html | http://build.fhir.org/ig/IHE/pharm-supply/index.html | ||
** a start has been made for | ** a start has been made for a product catalogue: | ||
** This has been split and put in a seperate repository/ | ** This has been split and put in a seperate repository/ | ||
https://github.com/IHE/pharm-catalog/tree/master | https://github.com/IHE/pharm-catalog/tree/master | ||
| Line 50: | Line 53: | ||
===Vaccination (Project lead Juergen)=== | |||
** Adverse Event Reporting. PAHO might be interested, but are not pushing. | ** Adverse Event Reporting. PAHO might be interested, but are not pushing. | ||
** Interest for a workshop? Jose will organize a workshop for the adverse event | |||
** Interest for a workshop? | |||
Revision as of 09:07, 4 February 2022
Minutes
Welcome
- Participants
- Trudy Hagg
- Anne van Berkel
- Hernany Silva Costa Melo
- Jose Costa Teixeira
- Quintin Ligier
- Sylvia Stein
- Marc Robberecht
- Michael Tan
- Joao Almeida
- Review and Approve Agenda
- Minutes of January : these were not made.
Planning Schedule
- Current version: Schedule 2021-2022
Work items
Strategy and stakeholder discussion
- Could the patient be a stakeholder? The aim is to improve the quality of information.
- In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles.
- In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID.
- In Switzerland Anne has to go the post office.
- Joao mentions that a product catalogue is important. Without this you cannot make a concise medication list..
- You also need an organization to maintain the medication structure for the catalogue.
- This topic is likely to be discussed in Unicom as well. We should approach Unicom to investigate if there is a need for a profile.
- Michael will approach Christian Hay to see if IHE Pharmacy could provide any added value
- Our team needs to set up a marketing plan.
- We need to identify the opportunities and work out the business case.
- Nowadays a standard can only be certified if it manages to reach a certain maturity level.
- That means that users have to implement the standard.
Supply (Project lead: Jose)
- White paper has been reviewed and updated. The documents can be found here:
https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr
- FHIR material:
https://github.com/IHE/pharm-supply http://build.fhir.org/ig/IHE/pharm-supply/index.html
- a start has been made for a product catalogue:
- This has been split and put in a seperate repository/
https://github.com/IHE/pharm-catalog/tree/master
Vaccination (Project lead Juergen)
- Adverse Event Reporting. PAHO might be interested, but are not pushing.
- Interest for a workshop? Jose will organize a workshop for the adverse event
- Medication record (Project lead Jose)
- No updates.
- ( in Belgium) currently dormant .
- suspend until new input has been received from Belgium or Italy
- Oncology medication management (Project lead Juergen)
- No news.
Any other business
- Jose will discuss a change proposal for the e-Prescription.
- This is partly because of Unicom.